← Back
A

$ Value

$1.7M

Shares

5,504

Price

$311

Filed

Mar 17

Insider

Name

Fitzpatrick Lynne

Title

President and CFO

CIK

0001915955

Roles

Officer

Transaction Details

Transaction Date

2026-03-15

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

26,428

Footnotes

Represents the vesting of performance shares granted in 2022 under CME Group's Omnibus Stock Plan. The number of shares was determined based on the company's achievement of total shareholder return relative to the S&P 500 measured over a three-year performance period from January 1, 2023 through December 31, 2025. | Ms. Fitzpatrick surrendered shares to the company in order to fulfill tax withholding obligations related to the receipt of the performance share award. | Ms. Fitzpatrick surrendered shares to the company to fulfill tax withholding obligations upon the vesting of restricted stock on 3/15/2026.

Filing Info

Accession No.

0001628280-26-018536

Form Type

4

Issuer CIK

0001156375

Fitzpatrick Lynne's History

Date Ticker Type Value
2026-03-15 CME A $1.7M
2026-03-15 CME F $760K
2026-03-15 CME F $24K
2025-09-16 CME F $98K
2025-09-15 CME F $165K
2025-09-15 CME A $1.1M

Other Insiders at CME (90d)

Insider Bought Sold Last
SHEPARD WILLIAM R $437K 2026-03-26
DUFFY TERRENCE A
Chairman and CEO
2026-03-15
GEPSMAN MARTIN J $92K 2026-02-20
Durkin Bryan T $1.3M 2026-02-23
Suskind Dennis $224K 2026-02-06
Piell Hilda Harris
Sr MD & Chief HR Officer
2026-03-15
Vroman Ken
Chief Transformation Officer
$1.6M 2026-03-15
Sammann Derek
Sr MD Gl Hd Commodities Mkts
2026-03-15
Cutinho Sunil
Chief Information Officer
2026-03-15
Tobin Jack J
MD Chief Accounting Officer
2026-03-15
Cook Elizabeth A $320K 2026-03-06
Winkler Julie
Sr MD Chief Commercial Officer
2026-03-15
Sprague Suzanne
COO & Global Head of Clearing
2026-03-15
Fitzpatrick Lynne
President and CFO
2026-03-15
McCourt Timothy Francis
Sr MD Global Head Equity & FX
2026-03-15
Marcus Jonathan L
Sr MD General Counsel
$1.0M 2026-03-17